BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 25998140)

  • 1. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern.
    Hasdemir C; Juang JJ; Kose S; Kocabas U; Orman MN; Payzin S; Sahin H; Celen C; Ozcan EE; Chen CJ; Gunduz R; Turan OE; Senol O; Burashnikov E; Antzelevitch C
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1078-1092. PubMed ID: 29953624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of atrial functional remodeling in patients with atrioventricular nodal reentrant tachycardia with and without drug-induced type 1 Brugada pattern: A case-control study.
    Kocabaş U; Payzın S; Hasdemir C
    J Clin Ultrasound; 2021 Jul; 49(6):573-579. PubMed ID: 33599988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.
    Sarica AS; Bor S; Orman MN; Barajas-Martinez H; Juang JJ; Antzelevitch C; Hasdemir C
    Am J Cardiol; 2021 Jul; 151():51-56. PubMed ID: 34034907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous atrioventricular nodal reentrant tachycardia in patients with idiopathic ventricular arrhythmias: the incidence, clinical, and electrophysiologic characteristics.
    Hasdemir C; Alp A; Simsek E; Kose N; Aydin M; Payzin S
    J Cardiovasc Electrophysiol; 2013 Dec; 24(12):1370-4. PubMed ID: 24016309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontact three-dimensional mapping guides catheter ablation of difficult atrioventricular nodal reentrant tachycardia.
    Lee PC; Tai CT; Lin YJ; Liu TY; Huang BH; Higa S; Yuniadi Y; Lee KT; Hwang B; Chen SA
    Int J Cardiol; 2007 May; 118(2):154-63. PubMed ID: 17023073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SCN10A variants associated with Brugada syndrome.
    Fukuyama M; Ohno S; Makiyama T; Horie M
    Europace; 2016 Jun; 18(6):905-11. PubMed ID: 25842276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome.
    Liu S; Yuan S; Hertervig E; Kongstad O; Olsson SB
    J Electrocardiol; 2001 Oct; 34(4):295-301. PubMed ID: 11590556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
    Hu D; Barajas-Martínez H; Medeiros-Domingo A; Crotti L; Veltmann C; Schimpf R; Urrutia J; Alday A; Casis O; Pfeiffer R; Burashnikov E; Caceres G; Tester DJ; Wolpert C; Borggrefe M; Schwartz P; Ackerman MJ; Antzelevitch C
    Heart Rhythm; 2012 May; 9(5):760-9. PubMed ID: 22155597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrocardiographic differentiation of common type atrioventricular nodal reentrant tachycardia from atrioventricular reciprocating tachycardia via a concealed accessory pathway.
    Letsas KP; Weber R; Siklody CH; Mihas CC; Stockinger J; Blum T; Kalusche D; Arentz T
    Acta Cardiol; 2010 Apr; 65(2):171-6. PubMed ID: 20458824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency current catheter ablation of accessory atrioventricular pathways.
    Trajkov I; Kovacevic D; Boskov V; Poposka L; Gjorgov N
    Prilozi; 2006 Dec; 27(2):71-87. PubMed ID: 17211293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.